Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F24L4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,231
Award facts
- Contract value 100% obligated
- $18,230.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,230.52 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, with completion expected by January 15, 2026. The contract covers the supply of Xifaxan 550 mg tablets (60-count packaging) under firm fixed-price terms with no set-aside designation, indicating open and competitive procurement. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distributor providing critical medical supplies to federal government agencies.
This delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This prime IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract demonstrates the company's established capability to fulfill federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism designed to support Department of Defense medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F24L4?
SPE2DR26F24L4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F24L4 worth?
The government has obligated $18,231 on SPE2DR26F24L4.
Is contract SPE2DR26F24L4 an order under another contract?
Yes. SPE2DR26F24L4 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F24L4 competed?
The extent of competition for SPE2DR26F24L4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award